Heinrich Heine University Düsseldorf was founded in 1965 as the successor organisation to Düsseldorf's Medical Academy of 1907 and was named after German poet Heinrich Heine. Following several expansions throughout the decades, the university has comprised five faculties since 1993.

During the past decade, Heinrich Heine Universitat Dusseldorf conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 14 clinical trials were completed, i.e. on average, 42.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heinrich Heine Universitat Dusseldorf" #1 sponsor was "Heinrich-Heine University, Duesseldorf" with 8 trials, followed by "Bayer" with 7 trials sponsored, "Celgene" with 3 trials sponsored, "Abbott" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heinrich Heine Universitat Dusseldorf" #1 collaborator was "Heinrich-Heine University, Duesseldorf" with 4 trials as a collaborator, "ASST Santi Paolo e Carlo" with 2 trials as a collaborator, "Bach Mai Hospital" with 2 trials as a collaborator, "Centro Hospitalar Lisboa Ocidental" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Heinrich Heine Universitat Dusseldorf" are "Myelodysplastic Syndromes" (5 trials), "Multiple Sclerosis" (4 trials), "Coronary Artery Disease" (3 trials), "HIV Infections" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Heinrich Heine Universitat Dusseldorf" in a lesser frequency.

Most popular intervention types in "Heinrich Heine Universitat Dusseldorf" are "Drug" (34 trials), "Other" (15 trials), "Procedure" (11 trials), "Device" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "Blood sampling" (2 trials), "Carboplatin" (2 trials), "Cocoa" (2 trials) and "Lenalidomide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Heinrich Heine Universitat Dusseldorf" are 64 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Heinrich Heine Universitat Dusseldorf". 1 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Heinrich Heine Universitat Dusseldorf, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Heinrich Heine Universitat Dusseldorf, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 15 trials that are defined as “Not Applicable".